The diagnosis of fetal alcohol syndrome.
The diagnosis of fetal alcohol syndrome.
复制标题
胎儿酒精综合症的诊断。
DOI:
10.3238/arztebl.2013.0703
复制
发表时间:
2013
影响因子:
7.7
通讯作者:
F. Heinen
中科院分区:
文献类型:
--
作者:
M. Landgraf;M. Nothacker;I. Kopp;F. Heinen
BACKGROUND
The estimated prevalence of fetal alcohol syndrome (FAS) is 8 for every 1000 live births. FAS has serious, lifelong consequences for the affected children and their families. A variety of professionals deal with persons who have FAS, including pediatricians, general practitioners, neurologists, gynecologists, psychiatrists, and psychotherapists. Early diagnosis is important so that the affected children can receive the support they need in a protective environment.
METHODS
A multidisciplinary guideline group has issued recommendations for the diagnosis of FAS after assessment of the available scientific evidence. This information was derived from pertinent literature (2001-2011) retrieved by a systematic search in PubMed and the Cochrane Library, along with the US-American and Canadian guidelines and additional literature retrieved by a manual search.
RESULTS
Of the 1383 publications retrieved by the searches, 178 were analyzed for the evidence they contained. It was concluded that the fully-developed clinical syndrome of FAS should be diagnosed on the basis of the following criteria: Patients must have at least one growth abnormality, e.g., short stature, as well as all three characteristic facial abnormalities-short palpebral fissure length, a thin upper lip, and a smooth philtrum. They must also have at least one diagnosed structural or functional abnormality of the central nervous system, e.g., microcephaly or impaired executive function. Confirmation of intrauterine exposure to alcohol is not obligatory for the diagnosis.
CONCLUSION
Practical, evidence-based criteria have now been established for the diagnosis of the fully-developed FAS syndrome. More research is needed in order to enable uniform, evidence-based diagnostic assessment of all fetal alcohol spectrum disorders and optimize supportive measures for the children affected by them.
登录
查看更多内容
DOI:
--
发表时间:
2011
期刊:
Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique
影响因子:
--
作者:
Astley,SusanJ
通讯作者:
Astley,SusanJ
影响因子:
2.3
作者:
Burd, Larry;Klug, Marilyn G.;Martsolf, John T.
通讯作者:
Martsolf, John T.
DOI:
10.1111/j.1530-0277.2002.tb02459.x
发表时间:
2002-10
期刊:
Alcoholism, clinical and experimental research
影响因子:
--
作者:
N. Day;S. Leech;G. Richardson;M. Cornelius;N. Robles;Cynthia A. Larkby
通讯作者:
N. Day;S. Leech;G. Richardson;M. Cornelius;N. Robles;Cynthia A. Larkby
DOI:
10.1093/cercor/bhm039
发表时间:
2008
期刊:
Cerebral cortex (New York, N.Y. : 1991)
影响因子:
--
作者:
Sowell,ElizabethR;Mattson,SarahN;Kan,Eric;Thompson,PaulM;Riley,EdwardP;Toga,ArthurW
通讯作者:
Toga,ArthurW
影响因子:
3.7
作者:
Yaling Yang;Florence F. Roussotte;E. Kan;K. Sulik;S. Mattson;E. Riley;K. Jones;C. Adnams;P. May-P.-M
通讯作者:
Yaling Yang;Florence F. Roussotte;E. Kan;K. Sulik;S. Mattson;E. Riley;K. Jones;C. Adnams;P. May-P.-M